Holger Rüssmann

Summary

Affiliation: HELIOS Klinikum Wuppertal
Country: Germany

Publications

  1. ncbi Inverted pathogenicity: the use of pathogen-specific molecular mechanisms for prevention or therapy of disease
    Holger Rüssmann
    Max von Pettenkofer Institut fur Hygiene und Medizinische Mikrobiologie, Ludwig Maximilians Universitat Munchen, Pettenkoferstrasse 9a, D 80336 MUnchen, Germany
    Int J Med Microbiol 293:565-9. 2004
  2. ncbi Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation
    Holger Rüssmann
    Max von Pettenkofer Institut fur Hygiene und Medizinische Mikrobiologie, Ludwig Maximilians Universitat Munchen, 80336 Munich, Germany
    Infect Immun 78:5138-50. 2010
  3. ncbi Rapid clearance of a recombinant Salmonella vaccine carrier prevents enhanced antigen-specific CD8 T-cell responses after oral boost immunizations
    Victòria E Sevil Domènech
    Max von Pettenkofer Institut fur Hygiene und Medizinische Mikrobiologie, Ludwig Maximilians Universitat Munchen, Pettenkoferstrasse 9a, 80336 Munich, Germany
    Microbes Infect 7:860-6. 2005
  4. ncbi Superior protective immunity against murine listeriosis by combined vaccination with CpG DNA and recombinant Salmonella enterica serovar typhimurium
    Christina Berchtold
    Max von Pettenkofer Institute for Hygiene and Medical Microbiology, Ludwig Maximilians University Munich, 80336 Munich, Germany
    Infect Immun 77:5501-8. 2009
  5. ncbi Pre-existing anti-Salmonella vector immunity prevents the development of protective antigen-specific CD8 T-cell frequencies against murine listeriosis
    Victòria E Sevil Domènech
    Max von Pettenkofer Institute for Hygiene and Medical Microbiology, Ludwig Maximilians University Munich, Pettenkoferstrasse 9a, 80336 Munich, Bavaria, Germany
    Microbes Infect 9:1447-53. 2007
  6. ncbi "One size fits it all": translocation of foreign antigens by Yersinia type III secretion system (TTSS) leads to concomitant CD4 and CD8 T-cell priming
    Holger Rüssmann
    Max von Pettenkofer Institut fur Hygiene und Medizinische Mikrobiologie, Ludwig Maximilians Universitat Munchen, Pettenkoferstrasse 9a, D 80336 MUnchen, Germany
    Int J Med Microbiol 294:313-7. 2004
  7. ncbi Heterologous prime-boost immunizations with different Salmonella serovars for enhanced antigen-specific CD8 T-cell induction
    Victòria E Sevil Domènech
    Max von Pettenkofer Institute for Hygiene and Medical Microbiology, Ludwig Maximilians University Munich, Pettenkoferstrasse 9a, 80336 Munich, Bavaria, Germany
    Vaccine 26:1879-86. 2008
  8. ncbi Salmonella type III-mediated heterologous antigen delivery: a versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors
    Klaus Panthel
    Max von Pettenkofer Institut fur Hygiene und Medizinische Mikrobiologie, Ludwig Maximilians Universitat Munchen, Pettenkoferstrasse 9a, D 80336 MUnchen, Germany
    Int J Med Microbiol 298:99-103. 2008
  9. ncbi Yersinia outer protein E, YopE. A versatile type III effector molecule for cytosolic targeting of heterologous antigens by attenuated Salmonella
    Holger Rüssmann
    Max von Pettenkofer Institut fur Hygiene und Medizinische Mikrobiologie, Ludwig Maximilians Universitat Munchen, Pettenkoferstrasse 9a, 80336 Munchen, Germany
    Adv Exp Med Biol 529:407-13. 2003
  10. ncbi Yersinia outer protein P inhibits CD8 T cell priming in the mouse infection model
    Konrad Trulzsch
    Max von Pettenkofer Institut fur Hygiene und Medizinische Mikrobiologie, Ludwig Maximilians Universitat, Munchen, Germany
    J Immunol 174:4244-51. 2005

Collaborators

  • Jurgen Heesemann
  • Carole Bourquin
  • Klaus Ruckdeschel
  • Klaus Panthel
  • Victòria E Sevil Domènech
  • Katrin M Meinel
  • Konrad Trulzsch
  • Christina Berchtold
  • Sebastian E Winter
  • Christian Lottspeich
  • Miriam Partilla
  • Stefan Jellbauer
  • Elisabeth Roider
  • Brigitte Köhn
  • Stefan Endres
  • Andrea Schwarzer
  • Sibylle Koletzko
  • Gernot Geginat
  • Thorsten Sporleder
  • Reinhardt Hoffmann

Detail Information

Publications12

  1. ncbi Inverted pathogenicity: the use of pathogen-specific molecular mechanisms for prevention or therapy of disease
    Holger Rüssmann
    Max von Pettenkofer Institut fur Hygiene und Medizinische Mikrobiologie, Ludwig Maximilians Universitat Munchen, Pettenkoferstrasse 9a, D 80336 MUnchen, Germany
    Int J Med Microbiol 293:565-9. 2004
    ..Surprisingly, cytosolic delivery of YopE/LLO by Yersinia also results in LLO-specific CD4 T-cell priming...
  2. ncbi Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation
    Holger Rüssmann
    Max von Pettenkofer Institut fur Hygiene und Medizinische Mikrobiologie, Ludwig Maximilians Universitat Munchen, 80336 Munich, Germany
    Infect Immun 78:5138-50. 2010
    ..We provide critical new insights into the interaction between the mammalian immune system and a human pathogen...
  3. ncbi Rapid clearance of a recombinant Salmonella vaccine carrier prevents enhanced antigen-specific CD8 T-cell responses after oral boost immunizations
    Victòria E Sevil Domènech
    Max von Pettenkofer Institut fur Hygiene und Medizinische Mikrobiologie, Ludwig Maximilians Universitat Munchen, Pettenkoferstrasse 9a, 80336 Munich, Germany
    Microbes Infect 7:860-6. 2005
    ....
  4. ncbi Superior protective immunity against murine listeriosis by combined vaccination with CpG DNA and recombinant Salmonella enterica serovar typhimurium
    Christina Berchtold
    Max von Pettenkofer Institute for Hygiene and Medical Microbiology, Ludwig Maximilians University Munich, 80336 Munich, Germany
    Infect Immun 77:5501-8. 2009
    ....
  5. ncbi Pre-existing anti-Salmonella vector immunity prevents the development of protective antigen-specific CD8 T-cell frequencies against murine listeriosis
    Victòria E Sevil Domènech
    Max von Pettenkofer Institute for Hygiene and Medical Microbiology, Ludwig Maximilians University Munich, Pettenkoferstrasse 9a, 80336 Munich, Bavaria, Germany
    Microbes Infect 9:1447-53. 2007
    ..Compared to the significantly higher numbers of p60-specific T lymphocytes elicited after single oral immunization, the low amount of Listeria-specific CD8 T cells did not confer protection against listeriosis...
  6. ncbi "One size fits it all": translocation of foreign antigens by Yersinia type III secretion system (TTSS) leads to concomitant CD4 and CD8 T-cell priming
    Holger Rüssmann
    Max von Pettenkofer Institut fur Hygiene und Medizinische Mikrobiologie, Ludwig Maximilians Universitat Munchen, Pettenkoferstrasse 9a, D 80336 MUnchen, Germany
    Int J Med Microbiol 294:313-7. 2004
    ..This "one-size-fits-it-all"-feature of Yersinia-translocated heterologous antigens might be advantageous to mount T-cellular immune responses against complex microbes and tumors...
  7. ncbi Heterologous prime-boost immunizations with different Salmonella serovars for enhanced antigen-specific CD8 T-cell induction
    Victòria E Sevil Domènech
    Max von Pettenkofer Institute for Hygiene and Medical Microbiology, Ludwig Maximilians University Munich, Pettenkoferstrasse 9a, 80336 Munich, Bavaria, Germany
    Vaccine 26:1879-86. 2008
    ....
  8. ncbi Salmonella type III-mediated heterologous antigen delivery: a versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors
    Klaus Panthel
    Max von Pettenkofer Institut fur Hygiene und Medizinische Mikrobiologie, Ludwig Maximilians Universitat Munchen, Pettenkoferstrasse 9a, D 80336 MUnchen, Germany
    Int J Med Microbiol 298:99-103. 2008
    ..This vaccination strategy can also be employed to efficiently protect mice from an aggressive fibrosarcoma transfected with p60 in a prophylactic setting...
  9. ncbi Yersinia outer protein E, YopE. A versatile type III effector molecule for cytosolic targeting of heterologous antigens by attenuated Salmonella
    Holger Rüssmann
    Max von Pettenkofer Institut fur Hygiene und Medizinische Mikrobiologie, Ludwig Maximilians Universitat Munchen, Pettenkoferstrasse 9a, 80336 Munchen, Germany
    Adv Exp Med Biol 529:407-13. 2003
    ..In orally immunized mice, this novel vaccination strategy results in the induction of pronounced peptide-specific cytotoxic CD8 T cell responses...
  10. ncbi Yersinia outer protein P inhibits CD8 T cell priming in the mouse infection model
    Konrad Trulzsch
    Max von Pettenkofer Institut fur Hygiene und Medizinische Mikrobiologie, Ludwig Maximilians Universitat, Munchen, Germany
    J Immunol 174:4244-51. 2005
    ..Using this approach we could further show that the listeriolysin O-specific CD8 T cells generated in vivo by the yopP mutant are functional and are able to protect mice against a lethal challenge with wild type Listeria...
  11. ncbi Attenuated Yersinia pseudotuberculosis carrier vaccine for simultaneous antigen-specific CD4 and CD8 T-cell induction
    Holger Rüssmann
    Max von Pettenkofer Institut fur Hygiene und Medizinische Mikrobiologie, Ludwig Maximilians Universitat Munchen, 80336 Munich, Germany
    Infect Immun 71:3463-72. 2003
    ..For the first time, it is shown that cytosolic antigen display mediated by an extracellular bacterial carrier vaccine results in simultaneous CD4 and CD8 T-cell priming, conferring protection against an intracellular pathogen...
  12. ncbi Evaluation of the novel Helicobacter pylori ClariRes real-time PCR assay for detection and clarithromycin susceptibility testing of H. pylori in stool specimens from symptomatic children
    Christian Lottspeich
    Max von Pettenkofer Institut fur Hygiene und Medizinische Mikrobiologie, Ludwig Maximilians University, Pettenkoferstr 9a, 80336 Munich, Germany
    J Clin Microbiol 45:1718-22. 2007
    ..7%) for the accurate diagnosis of H. pylori infection in children...